Novel intermediate for synthesizing topirastat and its preparation method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANGHAI INST OF PHARMA IND CO LTD
- Publication Date
- 2019-01-04
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of drug synthesis, and in particular relates to a new intermediate for synthesizing the drug topirastat for the treatment of gout, 4-(2-(imino(pyridin-4-yl)methyl)hydrazinecarbonyl)pyridine N-oxide , and a preparation method thereof. Background technique
[0002] Topiroxostat (Topiroxostat), the chemical name is 5-(2-cyano-4-pyridyl)-3-(4-pyridyl)-1,2,4-triazole, which is produced by Japan Fuji Pharmaceutical Co., Ltd. A new molecular entity drug developed and launched in Japan for the first time in August 2013. Its trade name is For the treatment of gout, hyperuricemia.
[0003] Chinese patent CN 1561340 discloses a method and route for synthesizing topirastat, see route 1 for details:
[0004]
[0005] This patent route (shown in Route 1) uses isonicotinic acid N-oxide as a raw material, and in the presence of 2-ethoxyl-1-ethoxycarbonyl-1,2-dihydroquinoline (abbreviated as EEDQ) and methanol Esterification t...